{"product_id":"europe-negative-pressure-wound-therapy-market-focused-insights-2023-2028","title":"Europe Negative Pressure Wound Therapy Market - Focused Insights 2023-2028","description":"\u003cp\u003eEurope Negative Pressure Wound Therapy Market - Focused Insights 2023-2028\u003cbr\u003e\nREPORT OVERVIEW\u003c\/p\u003e\n\n\u003cp\u003eThis report provides an in-depth analysis of the complete Europe NPWT market. Exhaustive information regarding the shift towards adopting innovative products in Europe. One of the major reasons for the lower adoption of NPWT products in the market is the need for reimbursement in some European countries. Constant product launches in the market from key vendors to gain market share is included. A constant increase in the number of target population is driving the market.\u003c\/p\u003e\n\n\u003cp\u003eThe economic burden of a wound per year in Europe is approximately $6500-$8000. Healthcare bodies are introducing multiple strategies and regulations to reduce the economic burden and to increase the adoption of advanced products for faster recovery and reducing re-admissions. The awareness among wound care specialists is increasing. Specialty wound care hospitals collaborate with large hospitals providing better care to the patients.\u003c\/p\u003e \n\n\u003cp\u003eMARKET DEFINITION\u003c\/p\u003e\n\n\u003cp\u003eNPWT is a wound care treatment that can be used for wounds on all parts of the body. It involves the application of negative pressure to the wound, which aids in reducing edema by removing excess fluid. Additionally, this therapy facilitates wound compression, thereby promoting the growth of new healthy tissue and the formation of blood vessels.\u003c\/p\u003e\n\n\u003cp\u003eKEY HIGHLIGHTS:\u003c\/p\u003e\n\n\u003cp\u003eThe number of diabetics, obese patients, and patients with co-morbidities is increasing constantly in Europe. This leads to an increase in pressure ulcers and prolonged healing of wounds. The increasing target population will drive the demand for NPWT in the European market.\u003c\/p\u003e\n\n\u003cp\u003eConventional NPWT market has a higher contribution as it has a higher adoption rate among healthcare professionals. The hospitals and wound care clinics are major end-users of NPWT products and constitute for major market share\u003c\/p\u003e\n\n\u003cp\u003eImproper reimbursement for the NPWT is one of the major reasons for the slower adoption of products in developed markets like Italy, France, and the UK\u003c\/p\u003e\n\n\u003cp\u003eThe awareness among people of wound care is very low. People prefer conventional treatments and choose not to go for advanced treatments. This is a major limitation for the adoption of NPWT treatments in EuropeThere is a constant increase in the number of surgeries performed in European countries. Increasing access to healthcare settings is increasing the number of elective surgeries. This will increase the demand for NPWT products in the market.VENDORS\u003c\/p\u003e\n\n\u003cp\u003eKey Vendors\u003c\/p\u003e\n\n\u003cp\u003eSmith+Nephew\u003c\/p\u003e\n\n\u003cp\u003e3M\u003c\/p\u003e\n\n\u003cp\u003eConvatech\u003c\/p\u003e\n\n\u003cp\u003eOther Prominent Vendors\u003c\/p\u003e\n\n\u003cp\u003eAlleva medical\u003c\/p\u003e \n\n\u003cp\u003eCardinal Health\u003c\/p\u003e \n\n\u003cp\u003eCarilex\u003c\/p\u003e\n\n\u003cp\u003eDeroyal\u003c\/p\u003e\n\n\u003cp\u003eGenadyne\u003c\/p\u003e \n\n\u003cp\u003eHaromed\u003c\/p\u003e\n\n\u003cp\u003eHartmann\u003c\/p\u003e\n\n\u003cp\u003eMedela\u003c\/p\u003e\n\n\u003cp\u003eMolnlycke\u003c\/p\u003e\n\n\u003cp\u003eLohmann \u0026amp; Rausch\u003c\/p\u003e\n\n\u003cp\u003eTalley Group\u003c\/p\u003e\n\n\u003cp\u003eTraiage Meditech\u003c\/p\u003e\n\n\u003cp\u003eREPORT HIGHLIGHTS\u003c\/p\u003e\n\n\u003cp\u003eSEGMENTATION \u0026amp; FORECASTProductConventional NPWT\u003c\/p\u003e\n\n\u003cp\u003eSingle Use NPWTEnd-UserHospitals\u003c\/p\u003e\n\n\u003cp\u003eWound Care Clinics\u003c\/p\u003e\n\n\u003cp\u003eASCs\u003c\/p\u003e\n\n\u003cp\u003eOthersWound TypeChronic Wound\u003c\/p\u003e\n\n\u003cp\u003eAcute WoundCountry AnalysisGermany\u003c\/p\u003e\n\n\u003cp\u003eFrance\u003c\/p\u003e\n\n\u003cp\u003eUK\u003c\/p\u003e\n\n\u003cp\u003eItaly\u003c\/p\u003e\n\n\u003cp\u003eSpain\u003c\/p\u003e\n\n\u003cp\u003eMARKET STRUCTUREMarket DynamicsCompetitive Landscape Key VendorsOther Prominent VendorsStrategic RecommendationsQuantitative SummaryAbbreviationsAPPENDIXResearch MethodologyAbbreviationsAbout Arizton\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"August, 2023 \/ 79 Pages \/ MCW16246949","offer_id":47662992884018,"sku":null,"price":2160.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/europe-negative-pressure-wound-therapy-market-focused-insights-2023-2028","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}